Lexicon Pharmaceuticals LXRX Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's change in AR?
- Lexicon Pharmaceuticals (LXRX) reported change in AR of $9.4M in Q1 2026.
- How has Lexicon Pharmaceuticals's change in AR changed year-over-year?
- Lexicon Pharmaceuticals's change in AR increased by 1015.7% year-over-year, from -$1.03M to $9.4M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.